A Phase 1 placebo-controlled, randomized, double-blind combined single and multiple ascending dose study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of RO5271983 in healthy subjects
Phase of Trial: Phase I
Latest Information Update: 10 Jun 2016
At a glance
- Drugs RG 7185 (Primary)
- Indications Asthma
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Roche
- 17 Jan 2012 Actual end date changed from May 2011 to Dec 2011 as reported by ClinicalTrials.gov.
- 05 Dec 2011 Actual patient number is 82 according to ClinicalTrials.gov.
- 05 Dec 2011 Actual end date (May 2011) added as reported by ClinicalTrials.gov.